An ontological modeling approach for abnormal states and its application in the medical domain

Yuki Yamagata, Kouji Kozaki, Takeshi Imai, Kazuhiko Ohe, Riichiro Mizoguchi, Yuki Yamagata, Kouji Kozaki, Takeshi Imai, Kazuhiko Ohe, Riichiro Mizoguchi

Abstract

Background: Recently, exchanging data and information has become a significant challenge in medicine. Such data include abnormal states. Establishing a unified representation framework of abnormal states can be a difficult task because of the diverse and heterogeneous nature of these states. Furthermore, in the definition of diseases found in several textbooks or dictionaries, abnormal states are not directly associated with the corresponding quantitative values of clinical test data, making the processing of such data by computers difficult.

Results: We focused on abnormal states in the definition of diseases and proposed a unified form to describe an abnormal state as a "property," which can be decomposed into an "attribute" and a "value" in a qualitative representation. We have developed a three-layer ontological model of abnormal states from the generic to disease-specific level. By developing an is-a hierarchy and combining causal chains of diseases, 21,000 abnormal states from 6000 diseases have been captured as generic causal relations and commonalities have been found among diseases across 13 medical departments.

Conclusions: Our results showed that our representation framework promotes interoperability and flexibility of the quantitative raw data, qualitative information, and generic/conceptual knowledge of abnormal states. In addition, the results showed that our ontological model have found commonalities in abnormal states among diseases across 13 medical departments.

Keywords: Abnormal state; Attribute; Disease; Interoperability; Ontology; Property.

Figures

Figure 1
Figure 1
Three-level ontological model of abnormal states. This figure shows an example of the three levels of structural abnormality of our abnormality ontology. “Level 1” defines generic concepts, which are object-independent states, e.g., “small in area.” “Level 2” defines object-dependent abnormal states. States at the upper levels of Level 2 are dependent on generic structures, such as the “narrowing tube” and “narrowing valve,” which are common and are used in several domains. Note that concepts at the lower level of the tree are specialized into medicine-specific concepts such as vascular stenosis, arterial stenosis, and coronary artery stenosis. “Level 3” defines disease-dependent concepts. For example, “coronary artery stenosis in angina pectoris” is defined as a constituent of the disease “angina pectoris” at Layer 3.
Figure 2
Figure 2
Top-level categories related to abnormal states. The top level categories of abnormal states are classified into three subclasses: “structural abnormality,” “functional abnormality,” and “other abnormality such as parametric/nonparametric change and so on”.
Figure 3
Figure 3
Types of ischemic heart disease constituted of causal chains. This figure shows a couple of causal chain-constituted ischemic heart disease. Each node shows the abnormal states, and each link indicates the causal relation between the abnormal states. A core causal chain of each disease is colored differently: ischemic heart disease is orange, and the subclasses of the ischemic heart disease, myocardial infarction are yellow. Prinzmetal angina is also a subclass of the ischemic heart disease consists of a pink core causal chain, and by an upstream extension smoking is added in the derived causal chain. Organic angina pectoris is green and the accumulation of cholesterol is added to the derived causal chain, which is a possible cause of arterial sclerosis.
Figure 4
Figure 4
Examples of hypertrophy constituted of causal chains. This figure shows two different uses of cardiac hypertrophy. Each cardiac hypertrophy is red. One usage is a constituent of a causal chain of the hypertensive heart disease in the cardiovascular department (upper figure), and the other is a constituent of a glycogenesis type II disease (Pompe disease) in the metabolic disease department shown below (A core causal chain of each disease is yellow).
Figure 5
Figure 5
Computational representation of abnormal states from generic to specific level. This figure shows the specialization of abnormal states from “small in area” to “ischemic heart disease specific coronary artery stenosis” using HOZO.
Figure 6
Figure 6
A visual editing tool for causal chains to define disease concepts. This is a screenshot of our visual editing tool for editing the definition of disease concepts. It visualizes the causal chains defined in a selected disease as a directed graph like that in Figure 3.

References

    1. Grenon P, Smith B, Goldberg L. Biodynamic ontology: applying BFO in the biomedical domain. Stud Health Technol Inform. 2004;102:20–38.
    1. Basic formal ontology. [ ]
    1. Guarino N. In: Proc. of International Conference on Lexical Resources and Evaluation 1998, Granada, Spain. Rubio A, Gallardo , Castro , Tejada , editor. 1998. Some ontological principles for designing upper level lexical resources; pp. 527–534.
    1. Mizoguchi R. YAMATO: Yet another more advanced top-level ontology. Proceedings of the Sixth Australasian Ontology Workshop, December 7, 2010. 2010. pp. 1–16.
    1. Masuya H, Mizoguchi R. An advanced strategy for integration of biological measurement data. The 2nd International Conference on Biomedical Ontology (ICBO2011): 28–30 July 2011; Buffalo, NY, USA. 2011. pp. 79–86.
    1. Gkoutos GV, Green EC, Mallon AM, Blake A, Greenaway S, Hancock JM, Davidson D. Ontologies for the description of mouse phenotypes. Comp Funct Genomics. 2004;5:545–51. doi: 10.1002/cfg.430.
    1. Yamagata Y, Kou H, Kozaki K, Imai T, Ohe K, Mizoguchi R. Ontological model of abnormal states and its application in the medical domain. The 4th International Conference on Biomedical Ontology (ICBO2013): 8–9 July 2013; Montreal, Qc, Canada. 2013. pp. 28–33.
    1. LOINC. [ ]
    1. Mizoguchi R, Kozaki K, Kou H, Yamagata Y, Imai T, Waki K, Ohe K. River flow model of diseases. The 2nd International Conference on Biomedical Ontology (ICBO2011): 28–30 July 2011. 2011. pp. 63–70.
    1. Mizoguchi R. Ontology Engineering. Tokyo: Ohmsha Ltd.; 2005.
    1. Peter HB, William CK. In: Joslin’s Diabetes Mellitus. 14. Kahn CR, editor. Vol. 19. 0: Lipplincott, Williams & Wilkins; 2005. Definition, diagnosis, and classification of diabetes mellitus and glucose homeostasis; pp. 331–332.
    1. Ito M. IGAKU-SHOIN’s Medical Dictionary. 2. Tokyo: Igaku-Shoin; 2010.
    1. Yamagata Y, Kou H, Kozaki K, Imai T, Ohe K, Mizoguchi R. Ontological modelling of interoperable abnormal states. Proc. of JIST2012, Nara, Japan, LNCS 7774. 2013. pp. 33–48.
    1. Kozaki K, Kou H, Yamagata Y, Imai T, Ohe K, Mizoguchi R. Browsing causal chains in a disease ontology. Poster & Demo Notes of 11th International Semantic Web Conference, Boston, USA. 2012. The Semantic Web Science Association (SWSA)
    1. Scheuermann RH, Ceusters W, Smith B. Toward an ontological treatment of disease and diagnosis. Proceedings of the 2009 AMIA Summit on Translational Bioinformatics, San Francisco, California. 2009. pp. 116–120. American Medical Informatics Association.
    1. World Health Organization. Diagnosis and Classification of Diabetes Mellitus and its Complications. Geneva: World Health Organization; 1999.
    1. Rector AL, Rogers JE, Pole P. The GALEN high level ontology. Studies in Health Technology and Informatics. 1996;34:174–178.
    1. Masuya H, Kozaki K, Ohe K, Mizoguchi R. Trial to develop a database of context-dependent phenotype data. Proc. of the 27th Annual conference of the Japanese Society for Artificial Intelligence. 2013. pp. 311–312.
    1. International Classification of Diseases (ICD) [ ]
    1. SNOMED Clinical Terms (SNOMED-CT) [ ]
    1. Schulz S, Suntisrivaraporn B, Baader F. SNOMED CT’s problem list: Ontologists' and Logicians' therapy suggestions. Stud Health Technol Inform. 2007;129(Pt 1):802–806.
    1. MEDIS. [ ]
    1. Ontology for General Medical Science (OGMS) [ ]
    1. Schriml LM, Arze C, Nadendla S, Chang YW, Mazaitis M, Felix V, Feng G, Kibbe WA. Disease Ontology: a backbone for disease semantic integration. Nucleic Acids Re. 2012;40(Database issue):D940–D946.
    1. Smith B, Ashburner M, Rosse C, Bard J, Bug W, Ceusters W, Goldberg LJ, Eilbeck K, Ireland A, Mungall CJ, Leontis N, Rocca-Serra P, Ruttenberg A, Sansone SA, Scheuermann RH, Shah N, Whetzel PL, Lewis S. OBI Consortium: The OBO Foundry: coordinated evolution of ontologies to support biomedical data integration. Nat Biotechnol. pp. 1251–1255.
    1. Kozaki K, Yamagata Y, Imai T, Ohe K, Mizoguchi R. Publishing a disease ontologies as linked data. In Proc. of JIST2013. 2013;0:0. in press,
    1. Stedman’s. Stedman’s Medical Dictionary. 6. Tokyo: Medical View Co Ltd; 2008.
    1. Ogawa S. Standard Textbook of Internal Medicine. Tokyo: Nakayama Shoten; 2009.
    1. Anthony S. Harrison’s Principle of Internal Medicine. 17. New York: McGraw Hill Medical; 2009.
    1. Imai T, Kou H, Zhou J, Kozaki K, Mozoguchi M, Ohe K. Japan medical ontology development project for advanced clinical information Systems. Proc. of 10th International HL7 Interoperability Conference 2009 (IHIC2009); Kyoto, Japan. 2009. pp. 42–46.
    1. HOZO. [ ]
    1. Disease Chain LOD. [ ]

Source: PubMed

3
Subskrybuj